Genexine (Korea) Market Value
| 095700 Stock | KRW 5,650 30.00 0.53% |
| Symbol | Genexine |
Genexine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genexine's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genexine.
| 12/04/2022 |
| 11/23/2024 |
If you would invest 0.00 in Genexine on December 4, 2022 and sell it all today you would earn a total of 0.00 from holding Genexine or generate 0.0% return on investment in Genexine over 720 days. Genexine is related to or competes with ABL Bio, and Medy Tox. Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherap... More
Genexine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genexine's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genexine upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 36.92 | |||
| Value At Risk | (4.38) | |||
| Potential Upside | 2.96 |
Genexine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genexine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genexine's standard deviation. In reality, there are many statistical measures that can use Genexine historical prices to predict the future Genexine's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.29) |
Genexine Backtested Returns
Genexine holds Efficiency (Sharpe) Ratio of -0.0588, which attests that the entity had a -0.0588% return per unit of risk over the last 3 months. Genexine exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genexine's Market Risk Adjusted Performance of (0.28), risk adjusted performance of (0.03), and Standard Deviation of 4.85 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.99, which attests to possible diversification benefits within a given portfolio. Genexine returns are very sensitive to returns on the market. As the market goes up or down, Genexine is expected to follow. At this point, Genexine has a negative expected return of -0.29%. Please make sure to check out Genexine's coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if Genexine performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.72 |
Good predictability
Genexine has good predictability. Overlapping area represents the amount of predictability between Genexine time series from 4th of December 2022 to 29th of November 2023 and 29th of November 2023 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genexine price movement. The serial correlation of 0.72 indicates that around 72.0% of current Genexine price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 1.4 M |
Genexine lagged returns against current returns
Autocorrelation, which is Genexine stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genexine's stock expected returns. We can calculate the autocorrelation of Genexine returns to help us make a trade decision. For example, suppose you find that Genexine has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Genexine regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genexine stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genexine stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genexine stock over time.
Current vs Lagged Prices |
| Timeline |
Genexine Lagged Returns
When evaluating Genexine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genexine stock have on its future price. Genexine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genexine autocorrelation shows the relationship between Genexine stock current value and its past values and can show if there is a momentum factor associated with investing in Genexine.
Regressed Prices |
| Timeline |
Pair Trading with Genexine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genexine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genexine will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Genexine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genexine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genexine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genexine to buy it.
The correlation of Genexine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genexine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genexine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genexine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Genexine Stock
Genexine financial ratios help investors to determine whether Genexine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genexine with respect to the benefits of owning Genexine security.